Anti-snoring Treatment Market
Key Takeaways
By Device Type: The Continuous Positive Airway Pressure (CPAP) devices segment holds the largest market share.
By Distribution Channel: The E-commerce segment captures the largest market share.
By Regional Insight: North America leads with the biggest revenue share.
Market Overview
Snoring in adults is a common issue, causing significant distress for both sufferers and their partners. Effective management requires a comprehensive approach including counseling, diagnostic evaluation, and personalized treatment. Despite evidence-based recommendations for some scenarios, the overall evidence for many diagnostic and therapeutic techniques remains limited. Diagnosis generally involves patient history and clinical examination, with polysomnography as the gold standard, supplemented by cardiorespiratory polygraphy when necessary. Conservative measures such as positional therapy and weight reduction are recommended, although the efficacy of myofascial therapies is uncertain. Mandibular advancement devices are a potential instrument-based treatment option. Surgical intervention may be necessary in cases of nasal breathing impairment or suspected soft palate abnormalities, with procedures tailored to individual anatomical suitability. It is important to note that snoring is not considered a disease, and treatment is pursued at the patient's discretion, emphasizing the importance of a patient-centered approach.
January 2024: DeRucci introduced new sleep health technologies, including a smart mattress, intelligent height-adjustable pillow, AI sleep monitoring, intelligent voice control panels, and curtain tracks.
Growth Factors
3D Digital Scanning Technology: The introduction of 3D digital scanning technology allows for the precise design and fabrication of oral appliances tailored to individual oral anatomy. These personalized appliances effectively reduce snoring and alleviate obstructive sleep apnea, enhancing sleep quality and driving market growth.
Specialized Sleep Studies: The market grows as healthcare providers increasingly rely on specialized sleep studies and evidence-based recommendations for diagnosing and treating snoring. Emphasis on conservative treatments like positioning therapy and weight loss attracts more patients seeking effective solutions, driving market expansion.
Posture Adjustment: A novel approach to preventing snoring through posture adjustment during sleep shows promising results. By widening the oropharynx space through cervical spine expansion and using dedicated pillows with adjustable angles, this method offers a non-invasive solution. Innovative products catering to consumer preferences for comfortable and user-friendly interventions stimulate market growth.
Anti-Snoring Beds: Anti-snoring beds, providing varying angles to optimize airway alignment during sleep, emerge as a valuable alternative to traditional positional therapy. Higher success rates in snoring cessation with larger angle interventions drive demand for these specialized beds, contributing to market expansion.
Market Dynamics
Drivers
Rising Awareness:
The National Healthy Sleep Awareness Project highlights snoring as a crucial indicator of obstructive sleep apnea, affecting approximately 30 million adults in the U.S. As awareness of the health risks associated with sleep apnea grows, demand for effective treatment solutions escalates. Surgical interventions and dental devices targeting anatomical causes of snoring improve airflow during sleep, propelling market expansion and presenting opportunities for growth and innovation.
Global Rise in Sleep Disorders:
Despite the widespread impact of sleep disorders, there is a significant gap in recognition and treatment. The prevalence of chronic insomnia in the U.S. ranges from 9% to 19%, with higher rates among women, minorities, and the elderly. As awareness grows regarding the importance of quality sleep, demand for interventions increases, driving market expansion. This presents a lucrative opportunity for healthcare providers and innovators to address unmet needs and drive growth.
Restraints
Challenges in Surgical Management:
The effectiveness and safety of surgical interventions for snoring and sleep apnea, such as laser-assisted uvulopalatoplasty and radiofrequency ablation, are hindered by limited evidence from small-scale randomized controlled trials. These studies fail to demonstrate significant improvements in key outcomes. Procedures like uvulopalatopharyngoplasty pose a risk of long-term side effects. Further research is needed to explore alternative surgical approaches, focusing on efficacy and safety to enhance treatment options.
Side Effects of Treatments:
The prevalence of side effects, such as short-term facial muscle problems and dental issues, presents a challenge to the widespread adoption of anti-snoring treatments, particularly Mandibular Advancement Devices (MAS). While these side effects are often minor, they can impact patient comfort and satisfaction, potentially deterring individuals from seeking or adhering to treatment, thus limiting market growth.
Opportunities
Mandibular Advancement Splints (MAS):
MAS therapy emerges as a leading alternative to CPAP for obstructive sleep apnea treatment. Properly fitted MAS effectively reduces snoring by advancing the mandible, widening the airway, and minimizing collapsibility. This innovative oral appliance offers a promising opportunity within the market, providing a comfortable and effective solution. As awareness and recognition of MAS therapy grow, there is considerable potential for market expansion.
Advancing Personalized Treatment:
The evolution towards personalized medicine in obstructive sleep apnea (OSA) treatment underscores the need to acknowledge individual variability among patients. Recent progress in addressing OSA heterogeneity signals a shift towards precision sleep medicine. With limited personalization currently practiced, there is significant opportunity for innovation. Developing tailored solutions to address individual patient needs and preferences can drive market growth and enhance patient outcomes.
Device Insights
Continuous Positive Airway Pressure (CPAP) devices dominate the landscape of anti-snoring treatments, providing a vital solution for maintaining open breathing airways during sleep through mild air pressure delivery. CPAP therapy is widely prescribed for sleep-related breathing disorders and beneficial for preterm infants with underdeveloped lungs. It offers numerous health advantages, including the prevention or control of high blood pressure, stroke risk reduction, and cognitive function enhancement. While CPAP remains the primary therapy, tailored recommendations from sleep specialists may lead to the adoption of alternative Positive Airway Pressure (PAP) devices based on individual circumstances.
June 2022: Illusion Aligners launched a new Anti-Snoring Device (ASD), designed for ease of use, effectiveness, and comfort.
Distribution Channel Insights
E-commerce has emerged as the dominant distribution channel for anti-snoring treatment products, offering a convenient platform for consumers to access a variety of brands such as AddBeauty, Digital Shoppy, Tirthtreads, and Onsafe (Nasal Strips). Digital Shoppy's snoring aids, made of silicone and plastic with embedded magnets to open nasal passages, promise side-effect-free relief. Tirthtreads provides nose clips in a protective case for comfortable insertion into nostrils. Innovations like smartphone application-administered upper airway training highlight the evolving landscape of snoring treatment through e-commerce platforms.
Regional Insights
North America stands as the largest market for anti-snoring solutions, driven by the high prevalence of obstructive sleep apnea (OSA) and a well-established network of healthcare professionals specializing in snoring and sleep apnea management. The American Academy of Dental Sleep Medicine (AADSM) plays a crucial role in advancing oral appliance therapy for snoring and sleep apnea in the U.S. With nearly 30 million adults affected by OSA, there is significant demand for comprehensive treatment options. While CPAP therapy remains prevalent, oral appliance therapy has emerged as a favored alternative. Other treatment options like positional therapy and upper airway stimulation further bolster the market in the region.
October 2021: KRONOS ADVANCED TECHNOLOGIES, INC. acquired a majority stake in Zyppah Inc., a company specializing in FDA-cleared anti-snoring devices for over-the-counter distribution.
February 2024: An anti-snoring device developed by a couple from Shelburne aims to preserve relationships.
Recent Developments
February 2021: Signifier Medical introduced a new era in sleep apnea and snoring treatment with the FDA's approval of the eXciteOSA Device.
February 2021: The FDA authorized a prescription-only device for snoring and mild sleep apnea.
Key Market Players
Apnea Sciences Corp.
SomnoMed Ltd.
Airway Management, Inc.
ResMed Inc.
Fisher & Paykel Healthcare Corp. Ltd.
Koninklijke Philips NV
Sleep Well Enjoy Life, Ltd.
Tomed Dr. Toussaint GmbH
MEDiTAS Ltd.
Segments Covered in the Report
By Device Type
Mandible Advancement Devices
Tongue Stabilizing Devices
Nasal Devices
Continuous Positive Airway Pressure Devices
Chin Straps
Others
By Distribution Channel
Hospitals
Clinics
Retail Pharmacies
E-commerce
Others
Regional Outlook
North America (U.S., Canada)
Europe (UK, Germany, France, Italy, Spain, Sweden, Norway, Denmark)
Asia Pacific (Japan, China, India, Australia, Thailand, South Korea)
Latin America (Brazil, Mexico, Argentina)
Middle East and Africa (Saudi Arabia, South Africa, UAE, Kuwait)
